Mice exhibited a loss in body and liver weight, elevated ALT and AST levels, and developed hepatic steatosis, along with a loss of WAT mass and increased NEFA plasma levels, similar to findings from our previous study (Supporting Information Fig. S1A–S1H, P < 0.01).7 The gene discussed is GPT; the disease is fatty liver disease.